warnings
Warnings Do not give to children under 2 years of age unless directed by a doctor.
Motion Sickness Relief
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Motion Sickness Relief
- Generic name
- DIMENHYDRINATE 50 MG
- Manufacturer
- TARGET CORPORATION
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 28586e9b-01e3-0b88-e063-6394a90af7e0
- SPL ID
- 2cd57ee4-448e-e087-e063-6294a90a78fa
- Version
- 2
- Effective date
- 2025-01-29
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:54:03
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M009 | openfda.application_number | |
| brand name | Motion Sickness Relief | openfda.brand_name | |
| generic name | DIMENHYDRINATE 50 MG | openfda.generic_name | |
| manufacturer name | TARGET CORPORATION | openfda.manufacturer_name | |
| ndc | package | 11673-354-24 | openfda.package_ndc |
| ndc | product | 11673-354 | openfda.product_ndc |
| ndc11 | package | 11673035424 | derived:openfda.package_ndc |
| rxcui | 198603 | openfda.rxcui | |
| spl id | 2cd57ee4-448e-e087-e063-6294a90a78fa | id | |
| spl set id | 28586e9b-01e3-0b88-e063-6394a90af7e0 | set_id | |
| unii | JB937PER5C | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.